4Charles A. Schiffer, Kenneth C. Anderson, Charles L.Bennett, et al: Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol, 2001, 19 (5) :1519-1538. 被引量：1
5Hannes Wandt, Gerhard Ehninger, Walter Michael Gallmeier et al: New strategies for prophylactic platelet transfusion in patients with hematologic diseases. The Oncologist, 2001, 6(5):446-450. 被引量：1
6Alcorta I, Pereira A, Ordinas A, et al. Clinical and laboratory factors associated with transfusion refractorieness a case-control study. Br J Haematol, 1996, 93(1) :220-224. 被引量：1
7Gil-Fernandez J J, Alegre A, Fernandez-Villalta M J,et al. Clinical results of a stringent policy on prophylactic platelet transfusion: Non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant, 1996, 18(5) :931-935. 被引量：1
8BernsteinS H, Nademanee A P, Vose J M, et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood, 1998, 91(9) :3509-3517. 被引量：1
9Nemo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT): Incidence and effect on survival-A quantitative analysis in 1 402 patients. Blood, 1998, 91(4) : 1469- 1477. 被引量：1
10Hogmen CF. Heamotherary with red cell concentrates and new red ce11 storage medium. Lancet,1998;1(19):26. 被引量：1
